ClinicalTrials.gov record
Completed Phase 3 Interventional

Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

ClinicalTrials.gov ID: NCT00091975

Public ClinicalTrials.gov record NCT00091975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Evaluate the Safety and Efficacy of Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

Study identification

NCT ID
NCT00091975
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
78 participants

Conditions and interventions

Conditions

Interventions

  • Zemplar Capsule Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2004
Primary completion
Not listed
Completion
Not listed
Last update posted
Jan 18, 2011

Started 2004

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
California Institute of Renal Research San Diego California 92120
Georgetown University Medical Center Washington D.C. District of Columbia 60057
Associates in Nephrology Fort Meyers Florida 33908
University of Florida Gainesville Florida 32610
Outcomes Research International, Inc. Hudson Florida 34667
Evanston Northwestern Healthcare Evanston Illinois 60201
Indiana University School of Medicine Indianapolis Indiana 46202
Tulane University School of Medicine New Orleans Louisiana 70112-2699
Washington University Medical Center St Louis Missouri 63108
St. Louis University St Louis Missouri 63110
Nea Research Las Vegas Nevada 89102
University of Cincinnati College of Medicine Cincinnati Ohio 45267-0585
Northwestern Renal Clinic, INC. Portland Oregon 97210
Nephrology Associates, P.C. Nashville Tennessee 37205
Kidney Associates, PLLC Houston Texas 77030
University of Texas Health Center at San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00091975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2011 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00091975 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →